Jonathon Cohen, MD, Oncology, Atlanta, GA, Emory University Hospital

JonathonBrettCohenMD

Oncology Atlanta, GA

Hematologic Oncology

Physician

Dr. Cohen is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Cohen's full profile

Already have an account?

Education & Training

  • Ohio State University Hospital
    Ohio State University HospitalFELLOWSHIP
  • Ohio State University Hospital
    Ohio State University HospitalRESIDENCY
  • University of Florida College of Medicine
    University of Florida College of MedicineMEDICAL_SCHOOL

Certifications & Licensure

  • GA State Medical License
    GA State Medical License 2013 - 2022
  • OH State Medical License
    OH State Medical License 2007 - 2015
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Intrathecal Central Nervous System Prophylaxis in Patients with Diffuse Large B-cell Lymphoma at an Academic Healthcare System  
    Jonathon Cohen, MD, Clinical Lymphoma, Myeloma, & Leukemia

Abstracts/Posters

  • Indolent Lymphoma and Vitamin D (ILyAD): A Double-Blind, Randomized, Placebo-Controlled Trial to Evaluate the Supplemental Effect of Vitamin D on Event-Free Survival i...
    Jonathon B. Cohen, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Multi-Institution Phase I/Ib Continual Re-Assessment Study to Identify the Optimal Dose of of Ibrutinib (IBR) and Venetoclax (VEN) in Relapsed or Refractory Mantle Cel...
    Jonathon B. Cohen, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Fitness and Anthracycline Use in Front-Line Therapy for Older Patients with Classical Hodgkin Lymphoma: A US Multi-Center Retrospective Analysis
    Jonathon B. Cohen, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Join now to see all

Lectures

  • Expert Perspectives on the Role of BTK Inhibitors in CLL 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • A Phase I/II Study of Ibrutinib and Ixazomib in Relapsed/Refractory Mantle Cell Lymphoma: PrE0404 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Clinical Trial Participation Is Associated with Improved Overall Survival in Newly Diagnosed Patients with Mantle Cell Lymphoma 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Join now to see all

Authored Content

  • ASH 2018: Novel Therapies for Relapsed/Refractory Aggressive LymphomasDecember 2018
  • ASH 2018: Novel Therapies for Relapsed/Refractory Aggressive LymphomasDecember 2018

Press Mentions

  • Trial Aims to Extend Remission for Patients with Mantle Cell Lymphoma
    Trial Aims to Extend Remission for Patients with Mantle Cell Lymphoma
  • OncLive® Presents State of the Science Summit™ on Hematologic Malignancies
    OncLive® Presents State of the Science Summit™ on Hematologic MalignanciesOctober 31, 2019
  • Nivolumab for Newly Diagnosed Advanced
    Nivolumab for Newly Diagnosed AdvancedApril 08, 2019
  • Join now to see all

Hospital Affiliations